Placebo-controlled, multicenter study of sertraline treatment for obsessive-compulsive disorder

Journal of Clinical Psychopharmacology

Volumn 19, Issue 2, 1999, Pages 172-176

  Kronig, Michael H ^a,c   Apter, Jeffrey ^b   Asnis, Gregory ^c   Bystritsky, Alexander ^d   Curtis, George ^e   Ferguson, James ^f   Landbloom, Ronald ^g   Munjack, Dennis ^h   Riesenberg, Robert ⁱ   Robinson, Delbert ^a,c   Roy Byrne, Peter ^j   Phillips, Kem ^k   Du Pont, Iwona Jeske ^k  

^a ZUCKER HILLSIDE HOSPITAL   (United States)

^b Princeton Biomedical Research   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^f Pharmacology Research Corporation   (United States)

^g REGIONS HOSPITAL   (United States)

^h Southwest Research Institute   (United States)

ⁱ Biobehavioral Research Center   (United States)

^j UNIVERSITY OF WASHINGTON   (United States)

^k PFIZER INC   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

SERTRALINE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBSESSION; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; TREATMENT OUTCOME;

ADULT; FEMALE; HUMANS; MALE; MIDDLE AGED; OBSESSIVE-COMPULSIVE DISORDER; PSYCHIATRIC STATUS RATING SCALES; SERTRALINE;

EID: 0032960056     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-199904000-00013     Document Type: Article

References (12)

1. Reimherr FW, Byerly WF, Ward MF, Lebegue BJ, Wender PH. Sertraline, a selective inhibitor of serotonin uptake, for the treatment of outpatients with major depressive disorder. Psychopharmacol Bull 1988;24:200-5.
2. Doogan DP, Caillard V. Sertraline in the prevention of depression. Br J Psychiatry 1992;160:217-22.
3. Chouinard G, Goodman W, Greist J, Jenike M, Rasmussen S, White K, Hackett E, Gaffney M, Bick PA. Results of a double-blind placebo-controlled trial of a new serotonin uptake inhibitor, sertraline, in the treatment of obsessive-compulsive disorder. Psychopharmacol Bull 1990;26:279-84.
4. Greist J, Chouinard G, DuBoff E, Halaris A, Kim SW, Koran L, Liebowitz M, Lydiard RB, Rasmussen S, White K, Sikes C. Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder. Arch Gen Psychiatry 1995;52:289-95.
5. Greist JH, Jefferson JW, Kobak KA, Chouinard G, DuBoff E, Halaris A, Kim SW, Koran L, Liebowitz MR, Lydiard B, McElroy S, Mendels J, Rasmussen S, White K, Flicker C. A 1 year double-blind placebo-controlled fixed dose study of sertraline in the treatment of obsessive-compulsive disorder. Int Clin Psychopharmacol 1995;10:57-65.
6. Spitzer RL, Williams JBW, Gibbon M, First MB. Structured Clinical Interview for DSM-III-R - patient edition (With Psychotic Screen) - SCID-P (w/Psychotic Screen), version 1:0. Washington, DC: American Psychiatric Press, Inc., 1990.
7. Goodman WK, Price LF, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, Heninger GR, Charney DS. The Yale-Brown obsessive compulsive scale: I. Development, use and reliability. Arch Gen Psychiatry 1989;46:1006-11.
8. Goodman WK, Price LH, Rasmussen SA, Mazure C, Delgado P, Heninger GR, Charney DS. The Yale-Brown Obsessive Compulsive Scale: II. Validity. Arch Gen Psychiatry 1989;46:1012-6.
9. Insel TR, Murphy DL, Cohen RM, Alterman I, Kilts C, Linnoila M. Obsessive-compulsive disorder: a double-blind trial of clomipramine and clorgyline. Arch Gen Psychiatry 1983;40:605-12.
10. Guy W, ed. ECDEU Assessment manual for psychopharmacology (publication ADM 76-338). Rockville, MD: U.S. Department of Health, Education, and Welfare, 1976.
11. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;1960:23:56-62.
12. Hamilton M. Development of a rating scale for primary depressive illness. Br J Clin Psychol 1967;6:278-96.